Acadian Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-135,324
| Closed | -$249K | – | 1970 |
|
2023
Q1 | $249K | Sell |
135,324
-962,504
| -88% | -$1.77M | ﹤0.01% | 1212 |
|
2022
Q4 | $1.22M | Buy |
1,097,828
+298,443
| +37% | +$331K | 0.01% | 800 |
|
2022
Q3 | $1.87M | Sell |
799,385
-21,942
| -3% | -$51.3K | 0.01% | 657 |
|
2022
Q2 | $2.49M | Buy |
821,327
+2,974
| +0.4% | +$9.01K | 0.01% | 574 |
|
2022
Q1 | $5.56M | Sell |
818,353
-76,871
| -9% | -$522K | 0.02% | 444 |
|
2021
Q4 | $7.47M | Buy |
895,224
+6,859
| +0.8% | +$57.3K | 0.03% | 360 |
|
2021
Q3 | $6.6M | Buy |
888,365
+184,446
| +26% | +$1.37M | 0.03% | 394 |
|
2021
Q2 | $4.79M | Buy |
703,919
+218,774
| +45% | +$1.49M | 0.02% | 477 |
|
2021
Q1 | $4.98M | Sell |
485,145
-67,483
| -12% | -$693K | 0.02% | 478 |
|
2020
Q4 | $3.87M | Sell |
552,628
-302,494
| -35% | -$2.12M | 0.02% | 576 |
|
2020
Q3 | $6.98M | Sell |
855,122
-114,562
| -12% | -$935K | 0.03% | 375 |
|
2020
Q2 | $6.69M | Buy |
969,684
+11,267
| +1% | +$77.7K | 0.03% | 417 |
|
2020
Q1 | $4.55M | Buy |
958,417
+278,939
| +41% | +$1.32M | 0.03% | 414 |
|
2019
Q4 | $5.93M | Buy |
679,478
+259,817
| +62% | +$2.27M | 0.03% | 402 |
|
2019
Q3 | $1.4M | Buy |
419,661
+43,571
| +12% | +$145K | 0.01% | 795 |
|
2019
Q2 | $1.86M | Buy |
376,090
+84,557
| +29% | +$419K | 0.01% | 644 |
|
2019
Q1 | $1.81M | Buy |
291,533
+151,576
| +108% | +$940K | 0.01% | 715 |
|
2018
Q4 | $471K | Buy |
139,957
+79,266
| +131% | +$267K | ﹤0.01% | 917 |
|
2018
Q3 | $395K | Buy |
60,691
+38,086
| +168% | +$248K | ﹤0.01% | 932 |
|
2018
Q2 | $173K | Sell |
22,605
-64,297
| -74% | -$492K | ﹤0.01% | 1123 |
|
2018
Q1 | $1.94M | Sell |
86,902
-157,054
| -64% | -$3.51M | 0.01% | 593 |
|
2017
Q4 | $3.11M | Sell |
243,956
-73,291
| -23% | -$935K | 0.01% | 463 |
|
2017
Q3 | $4.94M | Buy |
317,247
+149,048
| +89% | +$2.32M | 0.02% | 371 |
|
2017
Q2 | $2.36M | Buy |
+168,199
| New | +$2.36M | 0.01% | 542 |
|